2021 will be a massive year for acquisitions as there are many big pharmas cashed up and looking to beef up there pipelines. at a 1.6b market cap imugene is Chicken feed to these companies and the perfect target for an acquisition due to it having an umbrella of treatments. To those questioning the market cap of such an industry disruptor I suggest you go and check out what US biotechs are worth with much less up there sleeves.
2021 will be a massive year for acquisitions as there are many...
-
- There are more pages in this discussion • 22,587 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
-0.001(1.79%) |
Mkt cap ! $404.2M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.6¢ | 5.4¢ | $757.1K | 13.81M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 2203877 | 5.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.5¢ | 244428 | 4 |
View Market Depth
| Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |